Safety Study of Thioridazine in Combination With Cytarabine to Treat Relapsed or Refractory Acute Myeloid Leukemia
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
This is a Phase I trial investigating the safety of using thioridazine in addition to
cytarabine in elderly patients with relapsed or refractory Acute Myeloid Leukemia.
Phase:
Phase 1
Details
Lead Sponsor:
Ontario Clinical Oncology Group (OCOG)
Collaborators:
Hamilton Health Sciences Corporation Juravinski Cancer Centre Foundation